|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
EP0052322B1
(de)
|
1980-11-10 |
1985-03-27 |
Gersonde, Klaus, Prof. Dr. |
Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
DE3374837D1
(en)
|
1982-02-17 |
1988-01-21 |
Ciba Geigy Ag |
Lipids in the aqueous phase
|
|
DE3218121A1
(de)
|
1982-05-14 |
1983-11-17 |
Leskovar, Peter, Dr.-Ing., 8000 München |
Arzneimittel zur tumorbehandlung
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
DE3483949D1
(de)
|
1983-09-26 |
1991-02-21 |
Udo Dr Med Ehrenfeld |
Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
|
|
EP0143949B1
(en)
|
1983-11-01 |
1988-10-12 |
TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION |
Pharmaceutical composition containing urokinase
|
|
AU2935200A
(en)
|
1999-04-30 |
2000-11-17 |
Pfizer Products Inc. |
Compounds for the treatment of obesity
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
US8829198B2
(en)
*
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
|
US20050075375A1
(en)
*
|
2003-05-14 |
2005-04-07 |
Anadys Pharmaceuticals, Inc. |
Heterocyclic compounds for treating hepatitis C virus
|
|
DE102008020113A1
(de)
*
|
2008-04-23 |
2009-10-29 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte Dihydropyrazolone und ihre Verwendung
|
|
PL2004155T3
(pl)
*
|
2006-03-29 |
2018-08-31 |
Wista Laboratories Ltd. |
Inhibitory agregacji białek
|
|
US20110201686A1
(en)
*
|
2006-06-23 |
2011-08-18 |
Yousef Al-Abed |
Inhibitors of ASS and Synuclein Aggregation
|
|
JP4616237B2
(ja)
|
2006-11-07 |
2011-01-19 |
日本電信電話株式会社 |
シリコン化合物薄膜の形成方法
|
|
CN102047061A
(zh)
*
|
2008-05-30 |
2011-05-04 |
福斯特韦勒能源股份公司 |
通过氧化燃料燃烧发电的方法和系统
|
|
US20110293520A1
(en)
*
|
2008-06-09 |
2011-12-01 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
|
|
TW201120016A
(en)
|
2009-12-08 |
2011-06-16 |
Abbott Lab |
Novel oxadiazole compounds
|
|
PL3390412T3
(pl)
*
|
2015-12-14 |
2021-10-25 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Rozpuszczalne w wodzie pochodne związków 3,5-difenylodiazolowych
|
|
NZ746901A
(en)
*
|
2016-03-11 |
2023-06-30 |
Ac Immune Sa |
Bicyclic compounds for diagnosis and therapy
|
|
WO2019208509A1
(en)
|
2018-04-23 |
2019-10-31 |
Shionogi & Co., Ltd. |
Bicyclic heterocycle derivatives having selective bace1 inhibitory activity
|